LedX: A novel blood-based early lung cancer detection approach with exceptional accuracy and robustness
LedX, a noninvasive circulating tumor DNA methylation assay, demonstrated satisfactory sensitivity and specificity for lung cancer detection; thus, the model can be implemented in various clinical settings. Thus, LedX represents a potentially simple and cost-effective tool for the early screening and diagnosis of lung cancer.
Authors
- H. Wang
- R. Liu
- Kehui Xie
- Xiaobo Xu
- Zhixi Su
- Shimeng Ji
- X Y Tang
- Ning Ding
- Donghui Zhang
- Yong Zhang
- Jie Hu
- Yencheng Chao
- Chengcheng Ma
Institutions
- Liaoning University (CN)
- Fudan University (CN)
- Liaoning University of Technology (CN)
- Zhongshan Hospital (CN)
- Shanghai Pulmonary Hospital (CN)
- Sinotech Genomics (China) (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1097/cm9.0000000000003972
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00